Stephen Y Nakada, MD, FACS, FRCS (Glasg.)
Chairman, Department of Urology; The David T. Uehling Chair in Urology; Professor
Specialties: Adult Kidney Stones
UW Medical Foundation Centennial Building
1685 Highland Ave
MADISON, WI 53705-2281
- MD, University of Rochester School of Medicine and Dentistry, Rochester, NY, 1988
- Internship and Residency, Strong Memorial Hospital, University of Rochester, Rochester, NY, 1989-1994
- Fellowship, Endourology and Stone Disease, Barnes Hospital, Washington University, St. Louis, MO, 1994-1995
Dr. Nakada is certified by the American Board of Urology. He is an internationally renowned expert in urinary stones disease (urolithiasis) and urologic laparoscopy. In 1997, he performed and reported the first hand-assisted laparoscopic nephrectomy, in the United States, using a sleeve. In 2001, he was named Chairman of Urology and the first David T. Uehling Chair and Professor of Urology.
In 2003, Dr. Nakada became the 15th Dornier/A.F.U.D. Award Winner for Innovative Research in Urology. He has also been named the 2004 recipient of the Gold Cystoscope Award from the American Urological Association. Dr. Nakada has served on both the Staghorn Stone Guidelines Committee and the Distal Stones Guidelines Panel of the American Urological Association. He is listed in Best Doctors in America, Castle Connelly’s Top Doctors, and Madison Magazine’s Top Docs.
Dr. Nakada has authored or coauthored 250 scientfic articles and he has edited 9 textbooks. He has served on the ABU/AUA Examination Committee as well as editorial boards for Urology, the Journal of Endourology and Urology Times. Dr. Nakada is Past President of the Endourology Society and the American Board of Urology. He is currently a member of the the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons, among other societies.
Dr. Nakada’s research focuses on all aspects of urinary stone disease, specifically Quality of Life and Surgical Outcomes in urolithiasis. Dr. Nakada has co-inventor status regarding the WisQOL disease-specific instrument.